News

Regeneron declines to make higher bid for 23andMe after Wojcicki's $305 million offer
Regeneron Pharmaceuticals has declined to submit a new bid for genetic testing company 23andMe exceeding its original winning ...
GovInfoSecurity39m
ICO Imposes 2.31 Million Pound Fine on 23andMe
The British data regulator imposed a 2.31 million pound fine against bankrupt genetics research firm 23andMe for "serious" privacy violations tied to the ...
MedTech Dive1d
Anne Wojcicki wins bid to buy back 23andMe for $305M
A nonprofit led by the co-founder and former CEO of 23andMe outbid competitors for nearly all of the company’s assets.
Founder of 23andMe buys back company out of bankruptcy auction
TTAM Research Institute, a non-profit public benefit company also founded by Wojcicki, won the auction with a $305 million ...
Anne Wojcicki’s nonprofit wins bid to acquire genetic testing company 23andMe
The California-based nonprofit founded by the former 23andMe CEO is set to close the $305 million deal in coming weeks.
Anne Wojcicki's bid to buy back 23andMe may not end a legal fight over DNA customer data
Anne Wojcicki’s winning bid to reclaim control of 23andMe doesn’t necessarily end the fight over what happens to the DNA of ...
GovInfoSecurity1d
23andMe's Co-Founder to Buy Company; Makes Privacy Pledge
TTAM Research Institute - 23andMe's co-founder and former CEO Anne Wojcicki's new company - is the winner in a final round of ...